Mohamed Ismail Abdul Aziz (Kwong Ng)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Allergic Rhinitis

Acute Lymphoblastic Leukemia

Top Venues

Expert review of pharmacoeconomics & outcomes research

The Journal of asthma : official journal of the Association for the Care of Asthma

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Jen Cheng, Grace Wong, Wen-Yee Chay, Joanne Ngeow, Yongqiang Tan, Swee Sung Soon, Mohamed Ismail Abdul Aziz, Fiona Pearce, Kwong Ng
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer. Expert review of pharmacoeconomics & outcomes research 21 (3) (2021)
Li-Jen Cheng, Lydia Pui Yee Loke, Elaine Hsuen Lim, Fiona Pearce, Mohamed Ismail Abdul Aziz, Kwong Ng
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore. Expert review of pharmacoeconomics & outcomes research 21 (3) (2021)
Lydia Pui Yee Loke, Soo-Chin Lee, Fiona Pearce, Mohamed Ismail Abdul Aziz, Mohamed Ismail Abdul Aziz
Cost-effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore. Cancer reports (Hoboken, N.J.) 4 (1) (2020)
Ling Eng Tan, Wan Hui Gloria Tan, Mohamed Ismail Abdul Aziz, Mariko Siyue Koh, Tunn Ren Tay, Fiona Pearce, Mohamed Ismail Abdul Aziz
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore. The Journal of asthma : official journal of the Association for the Care of Asthma (2020)